Lv1
58 积分 2026-04-09 加入
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
13天前
已完结
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
1个月前
已完结
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
1个月前
已完结
皖公网安备34019202002308
